Refine
Has Fulltext
- yes (346)
Is part of the Bibliography
- yes (346)
Year of publication
Document Type
- Journal article (293)
- Doctoral Thesis (46)
- Book article / Book chapter (2)
- Conference Proceeding (2)
- Review (2)
- Preprint (1)
Language
- English (346) (remove)
Keywords
- Infektionsbiologie (57)
- Escherichia coli (27)
- Candida albicans (17)
- escherichia coli (11)
- gene expression (11)
- RNA-seq (9)
- Staphylococcus aureus (9)
- Immunologie (8)
- expression (8)
- infection (8)
- Biologie (7)
- virulence (7)
- epithelial cells (6)
- gene regulation (6)
- identification (6)
- pathogens (6)
- Malaria (5)
- RNA (5)
- Salmonella (5)
- activation (5)
- antimicrobial resistance (5)
- messenger RNA (5)
- plasmodium falciparum (5)
- sRNA (5)
- transcriptome (5)
- Dendritische Zelle (4)
- Genexpression (4)
- Hfq (4)
- Legionella pneumophila (4)
- Leishmania (4)
- Leishmania major (4)
- Neisseria meningitidis (4)
- antibiotics (4)
- antibodies (4)
- antisense RNA (4)
- bacteria (4)
- biofilms (4)
- inhibition (4)
- resistance (4)
- small RNA (4)
- synthesis (4)
- transcriptomics (4)
- vancomycin (4)
- Aspergillus fumigatus (3)
- COVID-19 (3)
- Campylobacter jejuni (3)
- Enterobacteriaceae (3)
- Evolution (3)
- Expression (3)
- Genregulation (3)
- Grad-seq (3)
- Pathogenität (3)
- RNA sequencing (3)
- RNA-binding proteins (3)
- RNS (3)
- SARS-CoV-2 (3)
- Salmonella Typhimurium (3)
- Salmonella enterica (3)
- Salmonella typhimurium (3)
- Small RNA (3)
- adaptation (3)
- antibacterial activity (3)
- autophagy (3)
- bacillus subtilis (3)
- biology (3)
- cancer (3)
- genes (3)
- genome sequence (3)
- leishmania major (3)
- leishmaniasis (3)
- macrophages (3)
- malaria (3)
- mechanisms (3)
- medicine (3)
- mouse models (3)
- protein kinase (3)
- regulatory RNA (3)
- riboswitch (3)
- sequence (3)
- signaling pathway (3)
- staphylococcus aureus (3)
- stem cells (3)
- substituent (3)
- transcription (3)
- transcription factors (3)
- translation (3)
- transmission (3)
- virulence factors (3)
- 3D tissue model (2)
- Agent (2)
- Antisense RNA (2)
- Bacteria (2)
- Bakterien (2)
- Biofilm (2)
- Breast-tumors (2)
- Cancer (2)
- Candida auris (2)
- DNA transcription (2)
- E. coli serotype 06 (2)
- F8 fimbriae (2)
- Fluconazole (2)
- Genanalyse (2)
- Gene regulation (2)
- Growth (2)
- HFQ (2)
- HeLa cells (2)
- Helicobacter pylori (2)
- Immunsystem (2)
- Impfung (2)
- In-vivo (2)
- Infection (2)
- Infektion (2)
- Integrine (2)
- Lung cancer (2)
- MATQ-seq (2)
- MRSA (2)
- Medizin (2)
- NSG (2)
- Nude-mice (2)
- Pathogens (2)
- Plasmodium falciparum (2)
- RNA synthesis (2)
- Rhodobacter sphaeroides (2)
- SEQ (2)
- Salmonellosis (2)
- Schwamm (2)
- Shigella (2)
- Stickstoff (2)
- Streptococcus pneumoniae (2)
- Streptomyces (2)
- Therapy (2)
- TraDIS (2)
- UTI (2)
- Virulenz (2)
- Virulenzfaktor (2)
- adhesion (2)
- allelic replacement (2)
- antibiotic resistance (2)
- antifungals (2)
- antigen (2)
- antisense RNAs (2)
- apoptosis (2)
- archaea (2)
- bacterial genetics (2)
- bioluminescence imaging (2)
- biosynthesis (2)
- candida albicans (2)
- cell wall (2)
- chaperone (2)
- comparative genomics (2)
- cytokines (2)
- cytotoxicity (2)
- dRNA-Seq (2)
- dendritic cells (2)
- enterica serovar typhimurium (2)
- epidemiology (2)
- evolution (2)
- fluorescence microscopy (2)
- gametocyte (2)
- gastric cancer (2)
- gastrointestinal tract (2)
- gene (2)
- gene cloning (2)
- gene expression profiling (2)
- genome (2)
- genome annotation (2)
- glycopeptide antibiotics (2)
- hemolysin (2)
- host cells (2)
- humanized mice (2)
- in vitro (2)
- in vivo imaging (2)
- in-vitro (2)
- in-vivo (2)
- inflammation (2)
- inhibitor (2)
- liraglutide (2)
- magnetic resonance imaging (2)
- mechanism (2)
- messenger-RNA (2)
- metabolism (2)
- metastasis (2)
- methionine (2)
- mutation (2)
- ncRNA (2)
- neuroimmunology (2)
- neutrophils (2)
- noncoding RNA (2)
- obesity (2)
- oncolytic virotherapy (2)
- oncolytic viruses (2)
- parasitic diseases (2)
- pathogenicity (2)
- phylogeny (2)
- plants (2)
- polycationic peptides (2)
- proteasome (2)
- protein kinases (2)
- proteins (2)
- recombination (2)
- red fluorescent protein (2)
- regulator (2)
- regulator genes (2)
- response regulator (2)
- responses (2)
- ribonucleases (2)
- secretion (2)
- secretion systems (2)
- signal transduction (2)
- single-cell RNA-seq (2)
- small RNAs (2)
- small nucleolar RNAs (2)
- strains (2)
- structure-activity (2)
- subunit (2)
- therapy (2)
- transmission electron microscopy (2)
- tumors (2)
- type VII secretion system (2)
- vaccinia virus (2)
- (+)-limonene (1)
- (Nucleotide sequence (1)
- 0 antigen (1)
- 2-component system (1)
- 3D Gewebemodelle (1)
- 3D cell culture (1)
- 3′ UTR (1)
- 5-bromodeoxyuridine (1)
- 6S RNA (1)
- AAV vector (1)
- AMP-activated kinases (1)
- APEC (1)
- ATG (1)
- ATG8 (1)
- AcrAB-TolC efflux pump (1)
- Adaptorproteine (1)
- Adherence (1)
- Adhesion (1)
- Adhäsion (1)
- Alkyltransferase Ribozyme SAMURI (1)
- Angeborene Immunität (1)
- Anopheles stephensi (1)
- Antigenpräsentation (1)
- Antimicrobial activity (1)
- Apicomplexan (1)
- Archaea (1)
- Arzneimitteldesign (1)
- Asthma (1)
- Asymptomatic Bacteriuria (1)
- Autotransporter (1)
- Avirulent Salmonella (1)
- BCG (1)
- BNIP3 (1)
- BT_1884 (1)
- Bacillus subtilis (1)
- Bacterial conjugation (1)
- Bacterial infection (1)
- Bacterial pathogens (1)
- Bacteriaophage AR9 (1)
- Bakterielle Infektion (1)
- Biofilm formation (1)
- Bioinformatics (1)
- Biology (1)
- Blood-brain barrier (1)
- Blutgefäß (1)
- Bordeiella pertussis (1)
- Bovine Mastitis (1)
- Bovis (1)
- Bradyrhizobium (1)
- Bronchialasthma (1)
- C-6-H (1)
- C-Terminus (1)
- CEACAM3 (1)
- COX-2 (1)
- CRISPR-Cas system (1)
- CRISPRs (1)
- CTSE (1)
- CUL4-DDB1 ubiquitin ligase (1)
- Calcium (1)
- Carcino-embryonales Antigen (1)
- Carcinoma (1)
- Cas9 (1)
- Cell binding (1)
- Characterization (1)
- Chemical modification (1)
- Chemotherapy (1)
- Chlamydia (1)
- Chlamydia pneumoniae (1)
- Chlamydien (1)
- Chlamydophila pneumoniae (1)
- Combination therapy (1)
- Complexome (1)
- CpG (1)
- Crohns-disease (1)
- CsrA (1)
- Cutaneous leishmaniasis (1)
- Cyanobacteria (1)
- Cyanobakterien (1)
- Cyclophosphamide (1)
- Cystic-fibriosis (1)
- DASH (1)
- DNA (1)
- DNA glycosation (1)
- DNA lang range mapping (1)
- DNA methylation (1)
- DNA methylferase homolog (1)
- Defensine (1)
- Deletion (1)
- Denaturierende Gradienten-Gelelektrophorese (1)
- Denaturing Gradient Gel Electrophoresis (1)
- Dendritic cell (1)
- Dendritic cells (1)
- Dendrtitischer Zellen (1)
- Dextran sulphate (1)
- Diarrhea (1)
- Disease gene prioritization (1)
- Division (1)
- Drug resistance (1)
- Dual 3'seq (1)
- Dual RNA-seq (1)
- E. coli Nissle 1917 (1)
- E. coli hemolysin (1)
- E. coli virulence (1)
- ECM (1)
- EGFP (1)
- ESAT‐6‐like secretion system (1)
- ESS (1)
- EZM (1)
- Efflux pump (1)
- Eingeweidewürmer (1)
- Eisen (1)
- Eisenmangel (1)
- Elektronisches Publizieren (1)
- Elektroporation (1)
- Enterica serovar typhimurium (1)
- Enterococcus faecalis (1)
- Enterococcus faecium (1)
- Environmental isolate (1)
- Epstein-Barr virus (1)
- Erwachsener (1)
- Erwinia amylovora (1)
- EsaA (1)
- Escherichia coli-Hfq (1)
- Escherichia-coli K-12 (1)
- Ethiopia (1)
- ExPEC (1)
- Excision (1)
- Extracellular matrix (1)
- F-19 MRI (1)
- F1 (1)
- FAK (1)
- Factor H (1)
- Family (1)
- Fimbria (1)
- Fimbriae (1)
- FinO family (1)
- Fitness (1)
- Fluconazol (1)
- Foc protein (1)
- Ftsz (1)
- Fusobacterium nucleatum (1)
- GFP (1)
- GI-101A tumor xenografts (1)
- GLP-1 (1)
- GLV-1 h153 (1)
- GLV-1H68 (1)
- GO1 (1)
- Gametozyt (1)
- Gene (1)
- Gene cloning (1)
- Gene expression (1)
- Gene mapping (1)
- Gene-expression (1)
- Gene-transfer (1)
- Genetik (1)
- Genome analysis (1)
- Genome re-annotation (1)
- Genomic profile (1)
- Genomik (1)
- Genomorganisation (1)
- Germany (1)
- GibS (1)
- Gifsy-1 (1)
- Glatte Muskulatur (1)
- Gram-positive bacteria (1)
- Grundsubstanz (1)
- H-NS (1)
- HBD2 (1)
- HD5 (1)
- HIV (1)
- Haemolysin (1)
- Haloferax volcanii (1)
- Harnwegsinfekt (1)
- Helicobacterpylori (1)
- Helminthen (1)
- Helminths (1)
- Hemolysin excretion (1)
- Herzmuskel (1)
- Hidden-Markov-Modell (1)
- Hirnhautentzündung (1)
- Histatin 5 (1)
- Histon-ähnliche Proteine (1)
- Histone-like proteins (1)
- Homology (1)
- Hospital water system (1)
- Hospitalismus <Hygiene> (1)
- Host adaptation (1)
- Host cells (1)
- Human-pathogenic (1)
- Hämolysin (1)
- IL-12 production (1)
- IL-4 (1)
- IL-4 Rezeptor alpha (1)
- IL-4 receptor alpha chain (1)
- ITAM (1)
- IcaR (1)
- Ileal Crohns-disease (1)
- Images (1)
- Immunbiologie (1)
- Immunisierung (1)
- Immunohistochemistry; Immunogold-silver staining; FITC- anti-FITC system; Leucocyte subpopulations; Two-color staining (1)
- Immunotherapy (1)
- Immunreaktion (1)
- Impfstoff (1)
- Impfungen (1)
- In-vitro (1)
- Inactivation (1)
- Infection models (1)
- Inflammation (1)
- Inhibitor (1)
- Integrin (1)
- Interferon <gamma-> (1)
- Interleukin 12 (1)
- Internal transcription start site (1)
- Invasion genes (1)
- Ire1 (1)
- Iron-oxide (1)
- Iron-uptake (1)
- Isolation and Characterization (1)
- IsrK (1)
- K279a (1)
- Kapsel (1)
- KhpB protein (1)
- Kinase (1)
- Kinasen (1)
- Klebsiella pneumoniae (1)
- Kleine Proteine (1)
- Koevolution (1)
- Krankheitsübertragung (1)
- Krebs <Medizin> (1)
- Langerhans cell (1)
- Leaderless transcript (1)
- Legionella ssp. (1)
- Legionellae (1)
- Leishmaniose (1)
- Lesions (1)
- Level (1)
- Library of Phytochemicals (1)
- Library of plant species (1)
- Listeria monocytogenes (1)
- Lungenkrebs (1)
- Lysis (medicine) (1)
- MACE (1)
- MDR1 (1)
- MET-T-box riboswitch (1)
- MI-2/NURD complex (1)
- MITE (1)
- MRI reporter (1)
- MRR1 (1)
- MRSA - methicillin-resistant Staphylococcus aureus (1)
- MTOR (1)
- MVT (1)
- Macrophage (1)
- Maintenance (1)
- Makrophage (1)
- Malariamücke (1)
- Malignant effusion (1)
- Mat Fimbrien (1)
- Mat fimbriae (1)
- Medicine (1)
- Medizinische Mikrobiologie (1)
- Meeresschwämme (1)
- Methanosarcina mazei (1)
- Methioninbiosynthese (1)
- MgrB (1)
- MicF (1)
- Mice (1)
- MicroRNAs (1)
- Microarray (1)
- Microscopy (1)
- Microwave Assisted Extraction (1)
- Mig1 (1)
- Mikroarray (1)
- Mikroskopie (1)
- Minor subunits (1)
- Mitteldarm (1)
- Molekulare Infektionsbiologie (1)
- Molekulargenetik (1)
- Mosquito (1)
- Mouse (1)
- Mrr1 (1)
- Multidrugresistant (1)
- Multiproteinkomplex (1)
- Mutant (1)
- Mycobacterium (1)
- Mäuse (1)
- Mücke (1)
- N-glycans (1)
- NAFLD (1)
- NAS (1)
- NASH (1)
- ND10 complex (1)
- NF-KAPPA-B (1)
- NK cells (1)
- NOTCH (1)
- NRG1 (1)
- NSG-SGM3 (1)
- Nature-Insipired Synthesis (1)
- Nck (1)
- Neisseria gonorrhoeae (1)
- Neugeborenes (1)
- Nichtrezeptor-Tyrosinkinasen (1)
- Nitrogen (1)
- Nodule (1)
- Non-coding RNA (1)
- Non-coding RNAs (1)
- Nonpathogenic Escherichia-coli (1)
- Nosocomial Infections (1)
- Nosokomiale Infektionen (1)
- OLFM4 (1)
- Oberflächenproteine der Sexualstadien (1)
- Oncolytic virotherapy (1)
- One Health (1)
- Open Science (1)
- Organoids (1)
- Orthogonal field attenuation gel electrophoresis (1)
- OxyR (1)
- P-fimbriae (1)
- P. falciparum (1)
- PCR (1)
- PEGylation (1)
- PETRI-seq (1)
- PFS25 (1)
- PIA/ica (1)
- PML (1)
- PML nuclear-bodies (1)
- PPGPP (1)
- PSI-blast (1)
- PYY3-36 (1)
- Paeonia (1)
- Pan1 (1)
- Parkinson's disease (1)
- Particles (1)
- Pathogene Bakterien (1)
- Pathogenicity (1)
- Pathogenitätsinseln (1)
- Pathologie (1)
- Pathology (1)
- PfAMA1 (1)
- PfCCp protein (1)
- Pflanzen (1)
- Pfs230 (1)
- Phagozytose (1)
- Pilus (1)
- PknB (1)
- Plant extracts (1)
- Plants (1)
- Plasmid (1)
- Polymeric Immunoglobulin receptor (1)
- Polysaccharide intercellular adhesin (PIA) (1)
- Porifera (1)
- ProQ (1)
- Probiotic (1)
- Probiotikum (1)
- Promoter (1)
- Promoter prediction (1)
- Proteasen (1)
- Protein (1)
- Protein function prediction (1)
- Proteine (1)
- Proteins (1)
- Proteogenomics (1)
- Proteomanalyse (1)
- Pseudomonas (1)
- Pseudomonas aeruginosa (1)
- Pseudomonas-aeruginosa (1)
- RFP (1)
- RNA Abbau (1)
- RNA CHAPERONE HFQ (1)
- RNA chaperone Hfq (1)
- RNA decay (1)
- RNA denaturation (1)
- RNA expression (1)
- RNA sequence analyses (1)
- RNA structure (1)
- RNA-Seq (1)
- RNA-binding protein (1)
- RNA-polymerase-I (1)
- RNA-polymerase-II (1)
- RNA-sequencing (1)
- RNAseq (1)
- RNS-Bindungsproteine (1)
- RNS-Spleißen (1)
- RNase E (1)
- RNase III (1)
- ROS (1)
- RTS,S/AS01 malaria vaccine (1)
- RYGB (1)
- Rapid evolution (1)
- Rats (1)
- Recombinant defensins (1)
- Recombinant vaccinia (1)
- Recombination directionality factor (1)
- Regression (1)
- Regulation (1)
- Rekombinante DNS (1)
- RelA (1)
- Reproducibility challenges (1)
- Resistance (1)
- Resistenz (1)
- Restenose (1)
- Ribosome profiling (1)
- Roux-en-Y gastric bypass surgery (1)
- S fimbrial adhesin (Sfa) (1)
- S-Fimbriae (1)
- S-fimbria (1)
- S-fimbriae (1)
- S. aureus (1)
- SAP2 (1)
- SER/THR kinase (1)
- SM-like protein (1)
- SNF1 (1)
- STEC (1)
- STP1 (1)
- SUBSP carotovora (1)
- SWI2/SNF2-like protein (1)
- Salmonella enterica Typhimurium strain SL1344 (1)
- Salmonella-enteritidis (1)
- Salmonella-typhimurium (1)
- Schistosoma japonicum; Egg antigen; Carbohydrate epitope; Circumoval precipitin test; Immunoassay (1)
- SdsR (1)
- Secretion (1)
- Sequence Analysis (1)
- Sequence identity (1)
- Sequencing (1)
- Sequenzanalyse (1)
- Serogroup (1)
- Serratia marcescens (1)
- Sexuelle Entwicklung (1)
- Shiga toxin-producing Escherichia coli (1)
- Shigellosis (1)
- Signalkette (1)
- Signaltransduktion (1)
- Site-specific RNA labelling (1)
- Snf1 (1)
- Soft-tissue infection (1)
- Southern hybridization (1)
- Speichel (1)
- Splicing (1)
- Sponge diseases (1)
- Src-Proteine (1)
- Staphylococcal infection (1)
- Staphylococcus (1)
- Staphylococcus aureus USA300 (1)
- Staphylococcus aureus immune response (1)
- Staphylococcus epidermidis (1)
- Staphylococcus-aureus (1)
- Stenotrophomonas maltophilia (1)
- Stickstoffmetabolismus (1)
- Stickstoffwechsel (1)
- Stp (1)
- StpA (1)
- Strain nissle-1917 (1)
- Strains (1)
- Stringent response (1)
- Stringente Antwort (1)
- Stringente Kontrolle (1)
- Sugar-transport (1)
- Suicide vector (1)
- SuperSAGE (1)
- Symbionts (1)
- Symbiose (1)
- Synthese (1)
- Synthesis (1)
- T cell (1)
- T cells (1)
- T helper cell (1)
- T lymphocytes (1)
- T-cell (1)
- TEM (1)
- TH1/TH2 (1)
- TRNA(ASP) (1)
- Th1 immunantwort (1)
- Th1 response (1)
- Thiostrepton (1)
- Tissue (1)
- Tissue Engineering (1)
- Toll-like receptors (1)
- Toxicity ; plasmids (1)
- Toxoplasma gondii (1)
- Tracking (1)
- Transcription (1)
- Transcription profiling (1)
- Transcription start site (1)
- Transcriptome (1)
- Transcriptome analysis (1)
- Transfektion (1)
- Transfer-RNA modification (1)
- Transkiptom (1)
- Transkription <Genetik> (1)
- Transkriptionsfaktor (1)
- Transkriptom (1)
- Transkriptomanalyse (1)
- Translation efficiency (1)
- Transmissionsblockierende Impfstoffe (1)
- Transposon (1)
- Transposon insertion sequencing (1)
- Typhimurium (1)
- UKZ (1)
- UME6 (1)
- UPEC (1)
- UPECs (1)
- Urinary tract (1)
- Urogenitalsystem (1)
- Uropatbcgenie E. coli (1)
- VEGF (1)
- Vaccines (1)
- Vaccinia virus (1)
- Vakuole (1)
- Valeriana wallichii (1)
- Variability (1)
- Variants (1)
- Vascular endothelial Growth Factor (1)
- Vertikale Weitergabe (1)
- Virologie (1)
- Virtual Research Environment (1)
- Virulence (1)
- Virusinfektion (1)
- WD40 (1)
- Wirtszelle (1)
- Yeast (1)
- Yersinia (1)
- Yersinia-pseudotuberculosis (1)
- YoelII-Nigeriensis (1)
- Ypk1 (1)
- Zoonotisches Risiko (1)
- abscesses (1)
- acetivorans C2A (1)
- acetones (1)
- acid (1)
- acrican trypanosomes (1)
- actinomycetes (1)
- activation mechanism (1)
- acute myeloid leukemia (1)
- adaptation phase (1)
- adults (1)
- agroinfiltration (1)
- alignment (1)
- alignment clustering (1)
- alpha defensins (1)
- alternative pig farming (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- ammonium (1)
- ammonium permease (1)
- animal model (1)
- animal models (1)
- animal-model (1)
- annotation (1)
- anti-biofilm (1)
- anti-schistosomal activity (1)
- anti-sigma factor (1)
- antibacterial (1)
- antibacterial drug resistance (1)
- antibacterials (1)
- antibiotic (1)
- antibiotic production (1)
- antifungal drug (1)
- antigen-presenting cells (1)
- antigenic variation (1)
- antimicrobial activity (1)
- antimicrobial peptides (1)
- antimicrobials (1)
- antitermination (1)
- arabidopsis (1)
- aspergillosis (1)
- aspergillus fumigatus (1)
- atypical tetracyclines (1)
- automation (1)
- autophagy-related (1)
- autotransporter (1)
- azobenzenes (1)
- bac-genomics-scripts (1)
- bacterial biofilms (1)
- bacterial genomes (1)
- bacterial genomics (1)
- bacterial immune evasion (1)
- bacterial infection (1)
- bacterial infection model (1)
- bacterial lipoproteins (1)
- bacterial migration (1)
- bacterial pathogen (1)
- bacterial physiology (1)
- bacterial resistance (1)
- bacterial secretion (1)
- bacterial signal molecule (1)
- bacterial transcription (1)
- bacterial virulence (1)
- bacteriology (1)
- bacteriophage (1)
- balancing selection (1)
- beta-glucuronidase (1)
- beta-lactamases (1)
- binding (1)
- binding protein HFQ (1)
- biocide polyhexamethylene biguanide (1)
- biofilm (1)
- biofilm regulation (1)
- biolog (1)
- biological scaffold (1)
- bioluminescence (1)
- bioorthogonal SAM analogue ProSeDMA (1)
- biophotonic imaging (1)
- biosynthetic gene-cluster (1)
- blood (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- blood-stream forms (1)
- brain endothelial cells (1)
- breast-tumors (1)
- broad-spectrum antibiotics (1)
- burkholderia cenocepacia (1)
- caffeic acid bornyl ester (1)
- campestris PV vesicatoria (1)
- campylobacter (1)
- cancer microenvironment (1)
- cancer treatment (1)
- cancers and neoplasms (1)
- candida (1)
- capsule (1)
- carbon metabolism (1)
- carcinoma (1)
- carcinomas (1)
- cardiac remodeling (1)
- carvacrol (1)
- casposon (1)
- catalytic (1)
- cell cultures (1)
- cell cycle (1)
- cell death (1)
- cell differentiation (1)
- cell fusion (1)
- cell signalling (1)
- cell vaccines (1)
- cell wall synthesis (1)
- cell-cycle arrest (1)
- cell-line (1)
- cepedia complex (1)
- chaperone HFQ (1)
- chaperone Hfq (1)
- characterization (1)
- chelocardins (1)
- children (1)
- chlamydomonas flagella (1)
- chromosomal genes (1)
- citral (1)
- citrus (1)
- clinical (1)
- clinical isolates (1)
- clonal analysis (1)
- co-infection (1)
- coagulase-negative staphylococci (1)
- coevolution (1)
- cold-shock protein (1)
- coli nissel 1917 (1)
- collaboratories (1)
- colony morphotypes (1)
- colorectal (1)
- colorectal cancer (1)
- community settings (1)
- comparative sequence analysis (1)
- complete genome sequence (1)
- complex (1)
- components (1)
- conditional mutants (1)
- conditional promoter replacement (1)
- conservation (1)
- conserving surgery (1)
- consesus (1)
- contact lens (1)
- controllability (1)
- cost-effectiveness (1)
- crystal structure (1)
- crystal-structures (1)
- cytolethal distending toxin (1)
- dRNA-seq (1)
- dark-matter (1)
- database (1)
- decay (1)
- deep sequencing (1)
- deepSuperSAGE (1)
- deficient mice (1)
- deletion mutagenesis (1)
- dependent gene-expression (1)
- dependent protein-kinase (1)
- derivatives (1)
- determines pathgenicity (1)
- diagnostic Microarray (1)
- diagnostischer Microarray (1)
- diarrhea (1)
- differential (1)
- directional RNA-Seq (1)
- disease (1)
- diseases of the nervous system (1)
- dogs (1)
- domain (1)
- domain genes A3(2) (1)
- down regulation (1)
- drospophila (1)
- drug (1)
- drug design (1)
- drug repurposing (1)
- drug resistance evolution (1)
- drug-delivery systems (1)
- dual RNA-seq (1)
- dual function (1)
- dynamic programming (1)
- ecoli_VF_collection (1)
- eigenvector centrality (1)
- electron tomography (1)
- electrophilic stress (1)
- elements (1)
- emotional behavior (1)
- emulsions (1)
- endocytosis (1)
- endoribonuclease (1)
- energy metabolism (1)
- enteric pathogens (1)
- enterica serovar thphimurium (1)
- entero-aggregative-haemorrhagic Escherichia coli (EAHEC) (1)
- enterobacteria (1)
- enterococci (1)
- environment (1)
- environmental regulation (1)
- enzyme APOBEC3G (1)
- enzyme-linked immunoassays (1)
- ephitelial cells (1)
- epithelial-mesenchymal transition (1)
- epithelium (1)
- escherichia coli K-12 (1)
- essential gene (1)
- essential genes (1)
- essential oils (1)
- ethanol (1)
- eugenyl cinnamate (1)
- eukaryotes (1)
- experimental visceral leishmaniasis (1)
- expression mutants (1)
- extracellular domain (1)
- extracellular enzymes (1)
- extraintestinal E. coli (1)
- extraintestinal isolates (1)
- extrapulmonary (1)
- falciparum (1)
- family (1)
- fatty acids (1)
- fibronectin-binding protein (1)
- filamentous Salmonella Typhimurium (1)
- finder using symmetrical best hits (1)
- flagellar basal body (1)
- flagellum (1)
- flotillin (1)
- flow cytometry (1)
- fluconazole resistance (1)
- fluorescence imaging (1)
- fluorescent probe (1)
- fluorescent protein (1)
- flux balance analysis (1)
- food industry (1)
- fostamatinib (1)
- functional genomics (1)
- fungal genetics (1)
- fungal pathogens (1)
- fungi (1)
- fungus (1)
- gallotannins (1)
- gamete (1)
- gametes (1)
- gastric bypass (1)
- gastrointestinal disease (1)
- gastrointestinal infections (1)
- gene expression heterogeneity (1)
- gene family targeting (1)
- gene probes (1)
- gene therapy (1)
- gene-cloning (1)
- gene-cluster (1)
- gene-expression (1)
- general stress response (1)
- genetic modification (1)
- genetic organization (1)
- genetic recombination (1)
- genetic transcription (1)
- genome organization (1)
- genome wide (1)
- genome-wide analysis (1)
- genomes (1)
- genomic deletions (1)
- genomic islands (1)
- genomic libraries (1)
- genomic library construction (1)
- genomics (1)
- genus Aspergillus (1)
- geometry (1)
- germination (1)
- global gene expression (1)
- glv-1h68 (1)
- glycolysis (1)
- glycosome (1)
- glycosyl phosphatidyl-inostitols. (1)
- gonococci (1)
- gram-negative bacteria (1)
- green fluorescent protein (1)
- growth (1)
- growth rate control (1)
- haemoproteus-columbae (1)
- halstedii JM8 (1)
- harmonia axyridis (1)
- harmonine (1)
- hela cells (1)
- helicobacter (1)
- hemolytic-uremic syndrome (1)
- heterogeneity (1)
- heterologous production (1)
- heteropathogenicity (1)
- hexose transporter (1)
- hidden markov-models (1)
- high-throughput sequencing (1)
- histidine kinases (1)
- histology (1)
- homologs (1)
- homology search (1)
- horizontal gene transfer (1)
- hos tcells (1)
- host (1)
- host (organism) (1)
- host colonization (1)
- host pathogen interaction (1)
- host-cell invasion (1)
- host-pathogen-interaction (1)
- human factor H (1)
- human herpesvirus 6 (1)
- human macrophages (1)
- human pathogenic fungi (1)
- human pathogens (1)
- human sodium iodide symporter (hNIS) (1)
- humaner Faktor H (1)
- humanized hemato-lymphoid mice (1)
- hybrid (1)
- hydrogen regulation (1)
- hydrogen-peroxide (1)
- hyperexpression techniques (1)
- hypersensitive response (1)
- hyperthermophile (1)
- hyphae (1)
- hypothalamic gene expression (1)
- icaADBC (1)
- immune response (1)
- immune sytem (1)
- immunity (1)
- immunization (1)
- immunodeficiency-virus type-1 (1)
- in vivo (1)
- in-vitro propagation (1)
- inactivation (1)
- infection biology (1)
- infectious disease (1)
- inflammatory bowel disease (1)
- inflammatory-bowel-disease (1)
- inhibitors (1)
- insect immunity (1)
- insights (1)
- integration (1)
- interaction surfaces (1)
- interactome (1)
- interferon-gamma (1)
- intermediate host (1)
- internalization (1)
- intervention strategies (1)
- interview (1)
- intestinal enteroids (1)
- intracellular pathogen (1)
- intracellular pathogens (1)
- invasion (1)
- iron (1)
- iron limitation (1)
- island (1)
- isolation (1)
- kinase (1)
- kingdom (1)
- latency (1)
- lead structure (1)
- leaves (1)
- legionella pneumophila (1)
- leishmania (1)
- leishmaniose (1)
- libraries (1)
- library screening (1)
- life cycle (1)
- lines (1)
- linker influence (1)
- lipids (1)
- liquid chromatography-mass spectrometry (1)
- listeria monocytogenes (1)
- livestock-associated staphylococci (1)
- locus (1)
- luciferase (1)
- lux (1)
- lymph nodes (1)
- lymphadenitis (1)
- lytic replication (1)
- mC (1)
- mCherry (1)
- macrophage infection (1)
- malaria parasite (1)
- malaria vaccine (1)
- maps (1)
- marine sponges (1)
- mass spectrometry (1)
- mastectomy (1)
- mastitis-associated Escherichia coli (MAEC) (1)
- maternal separation (1)
- mating (1)
- maturation (1)
- mechanism of resistance (1)
- mechanisms of disease (1)
- membrane (1)
- membrane proteins (1)
- membrane vesicles (1)
- membrane-protein topology (1)
- meningococcus (1)
- merozoite (1)
- messanger RNA (1)
- messenger-RNA decay (1)
- meta-analysis based orthology (1)
- metabolic adaptation (1)
- metastases (1)
- methanoarchaea (1)
- methanol methyltransferase isozymes (1)
- methanosarcina mazei GO1 (1)
- methicillin (1)
- methionine biosynthesis (1)
- miRNAs (1)
- mice (1)
- microRNAs (1)
- microSPLiT (1)
- microarray (1)
- microbial diversity (1)
- microbial ecology (1)
- microbiology (1)
- microbiome (1)
- microbiota (1)
- microenvironment (1)
- microneme (1)
- microtubule motor (1)
- midgut (1)
- migration (1)
- mikrobielle Diversität (1)
- mikrobielle Ökologie (1)
- mitochondria (1)
- model (1)
- modulation of virus replication (1)
- molecular epidemiology (1)
- molecular evolution (1)
- monocyte (1)
- morphogenesis (1)
- mouse (1)
- mucosal inflammation (1)
- multidrug-resistant bacteria (1)
- multivesicular tubule (1)
- murine leishmaniasis (1)
- mycobacterium tuberculosis (1)
- mycobacterium-tuberculosis (1)
- myelin biology and repair (1)
- myeloma (1)
- natively unstructured protein (1)
- natural antisense transcripts (1)
- natural transformation (1)
- necrosis-factor-alpha (1)
- neisseria gonorrhoeae (1)
- network biology (1)
- nitrogen regulation (1)
- non-aureus staphylococci (1)
- non-coding RNA (1)
- noncoding RNAs (1)
- nondocing RNA (1)
- norovirus (1)
- northern blotting (1)
- nosocomial pathogen (1)
- nucleotide sequence (1)
- nude-mice (1)
- nutrients (1)
- olfactomedin 4 (1)
- oligopeptide transport (1)
- oligopeptides (1)
- oncolytic viral therapy (1)
- oncolytic virus (1)
- one-health approach (1)
- organic farming (1)
- organization (1)
- organohalide respiration (1)
- organoid culture (1)
- organoids (1)
- origin (1)
- orthology (1)
- orthology network (1)
- outbreak (1)
- outer-membrane proteins (1)
- oviedomycin (1)
- oxidative stress (1)
- pangolin (1)
- par-seqFISH (1)
- parallel evolution (1)
- parasexual recombination (1)
- parasite (1)
- parasitology (1)
- paromomycin (1)
- pathogen (1)
- pathogen-associated molecular pattern (1)
- pathogenesis (1)
- pathogenetic organism (1)
- pathogenic bacteria (1)
- pathogenicity island 2 (1)
- pathogenicity islands (1)
- pathotypes (1)
- peptide (1)
- peptide conjugates (1)
- peptide tyrosine tyrosine (PYY) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- peptido-glycan associated protein (1)
- permease (1)
- persistence (1)
- persister cells (1)
- phage (1)
- phagocytes (1)
- phagocytosis (1)
- pharmacokinetics (1)
- phased metamorphosis (1)
- phenotypic heterogeneity (1)
- phenotypic microarray (1)
- pheromones (1)
- phosphorylation (1)
- photooxidative stress (1)
- photosynthesis genes (1)
- phototrophic growth (1)
- phylogenetic analysis (1)
- phylogenetic trees (1)
- phytochemicals (1)
- pig farming methods (1)
- plant-made vaccines (1)
- plant-microbe interaction (1)
- plasmid-chromosome crosstalk (1)
- plasmodium (1)
- plastid targeting (1)
- platelet (1)
- point mutation (1)
- polyadenylation sites (1)
- polycistronic transcription (1)
- polymerase chain reaction (PCR) (1)
- porphyromonas gingivalis (1)
- positive selection (1)
- post-transcriptional regulation (1)
- post-transcriptionalregulation (1)
- posttranscriptional control (1)
- ppl (1)
- pre-messenger RNA (1)
- promastigotes (1)
- promoters (1)
- prophage (1)
- protease (1)
- protein (1)
- protein HFQ (1)
- protein expressions (1)
- protein families database (1)
- protein kinase signaling cascade (1)
- protein synthesis (1)
- protein-RNA recognition (1)
- protozoan parasite (1)
- pseudomas aeruginosa (1)
- pulmonary (1)
- purification (1)
- pyrococcus furiosus (1)
- quanititative proteomics (1)
- quinone (1)
- rRNA depletion (1)
- radiation-therapy (1)
- radioiodine therapy (1)
- ralstonia solanacearum (1)
- rat (1)
- receptor (1)
- receptors (1)
- reciprocal best hit (1)
- recombinant proteins (1)
- regionalization and organoids (1)
- regulation (1)
- regulatory small RNAs (1)
- remote sequence conservation (1)
- replication (1)
- reporter (1)
- reporter genes (1)
- repression (1)
- reputation (1)
- resistance mechanism (1)
- resistance-breaking properties (1)
- resistant Staphylococcus-aureus (1)
- restenosis (1)
- reveals (1)
- rhodobacter sphaeroides (1)
- ribosomal RNA (1)
- rotavirus (1)
- sRNA atlas (1)
- sRNA biogenesis (1)
- salmonella (1)
- salmonella enterica (1)
- sationary phase (1)
- scaffold protein (1)
- schistosoma (1)
- schistosomula (1)
- scholarly publishing (1)
- scientific publishing (1)
- screening (1)
- secondary structure (1)
- segmentation (1)
- sequence motif analysis (1)
- sequences (1)
- sequencing protocol (1)
- serotonin (1)
- serovar Typhimurium (1)
- serum resistance (1)
- sexual stage (1)
- sexual stage surface proteins (1)
- sfaA gene) (1)
- shiga toxin (1)
- shock sigma factor (1)
- siRNAs (1)
- sigma factor (1)
- signal-transduction systems (1)
- signaling network (1)
- simultaneous (1)
- singlet oxygen stress (1)
- sinorhizobium fredii NGR234 (1)
- skin fatty acid (1)
- small interfering RNAs (1)
- small non-coding RNAs (1)
- small noncoding RNAs (1)
- small proteins (1)
- small regulatory RNAs (1)
- sodium-iodide symporter (1)
- solubility (1)
- soluble-RNA (1)
- soluble-RNAs (1)
- sortase A (1)
- specificity (1)
- sponge (1)
- spores (1)
- stability (1)
- stage-i (1)
- staib agar (1)
- staphilococci (1)
- staphylocccal infection/epidemiology (1)
- staphylococcal abscess (1)
- staphylococcus (1)
- stationary phase (1)
- stomach (1)
- strain (1)
- strain Newman (1)
- streptococcus pneumoniae (1)
- stress resistance (1)
- stress response (1)
- stringency (1)
- structural elucidation (1)
- structural modification (1)
- structure activity (1)
- structure-activity relationship (1)
- structure–activity (1)
- subcellular localization (1)
- subpopulation (1)
- subtilis genome (1)
- sulfates (1)
- sulfur (1)
- suppressor mutation (1)
- surgery (1)
- synthetase (1)
- tag based (1)
- tandem mass-spectra (1)
- target (1)
- target recognition (1)
- tetrachloroethene (1)
- thiostrepton (1)
- thymyl cinnamate (1)
- thyroid-cancer (1)
- tobacco (1)
- toll-like receptor 2 (1)
- topical treatment (1)
- toxin (1)
- trans-activation (1)
- transcription factor (1)
- transcription initiation site (1)
- transcription regulator (1)
- transcription start site (1)
- transcription start sites (1)
- transcriptional control (1)
- transcriptional landscape (1)
- transcriptional regulation (1)
- transcriptional regulator (1)
- transcriptional start site (1)
- transcriptional uni (1)
- transcriptome analysis (1)
- transcriptomeanalysis (1)
- transfection (1)
- transfer (1)
- transfer RNA (1)
- transkiptome (1)
- translation initiation (1)
- translational initiation (1)
- translocation (1)
- transmission blocking vaccine (1)
- transport (1)
- transport systems (1)
- transposable elements (1)
- transposition (1)
- tuberculosis (1)
- two-component systems (1)
- two‐component system (1)
- type III protein secretion system complex (1)
- type III secretion system pathways (1)
- tyrosine kinase (1)
- ubiquitin (1)
- ulcreative colitis (1)
- untranslated regions (1)
- urinary tract infection (1)
- urinary tract infection (UTI) (1)
- urinary-tract-infection (1)
- uropathogenic Escherichia coli (1)
- uropathogenicity (1)
- uropathogens (1)
- vaccine (1)
- vaccines (1)
- vacuole (1)
- vacuoles (1)
- variant surface glycoprotein (1)
- version control (1)
- vertical transmission (1)
- vibrio parahaemolyticus (1)
- viral protein-R (1)
- viral replication (1)
- virotherapy (1)
- virulence genes (1)
- virulence modulation (1)
- virus-infection (1)
- visceral leishmaniasis (1)
- wikis (1)
- workflow platform (1)
- xanthomonas (1)
- xanthomonas campestris (1)
- xanthomonas maltophilia (1)
- yeast (1)
- yvcK/glmR operon (1)
- zinc cluster transcription factor (1)
- zoonotic (1)
- zoonotic risk (1)
- Übertrag (1)
Institute
- Institut für Molekulare Infektionsbiologie (346) (remove)
Sonstige beteiligte Institutionen
- Genelux Corporation, San Diego Science Center, 3030 Bunker Hill Street, Suite 310, San Diego, California 92109, USA (1)
- Helmholtz Center for RNA-based Infection Research (1)
- Institut für Molekulare Infektionsbiologie (MIB) der Universität Würzburg (1)
- MRB Forschungszentrum für Magnet-Resonanz-Bayern e.V., Am Hubland, D-97074 Würzburg (1)
- Research Center for Infectious Diseases (ZINF), University of Wuerzburg, Wuerzburg, Germany, (1)
- Research Center of Infectious Diseases (ZINF) of the University of Wurzburg, Germany (1)
- Universitätsklinikum Münster (1)
- Zentrum für Infektionsforschung (ZINF): Nachwuchsgruppe 2 (1)
An expanded evaluation of protein function prediction methods shows an improvement in accuracy
(2016)
Background
A major bottleneck in our understanding of the molecular underpinnings of life is the assignment of function to proteins. While molecular experiments provide the most reliable annotation of proteins, their relatively low throughput and restricted purview have led to an increasing role for computational function prediction. However, assessing methods for protein function prediction and tracking progress in the field remain challenging.
Results
We conducted the second critical assessment of functional annotation (CAFA), a timed challenge to assess computational methods that automatically assign protein function. We evaluated 126 methods from 56 research groups for their ability to predict biological functions using Gene Ontology and gene-disease associations using Human Phenotype Ontology on a set of 3681 proteins from 18 species. CAFA2 featured expanded analysis compared with CAFA1, with regards to data set size, variety, and assessment metrics. To review progress in the field, the analysis compared the best methods from CAFA1 to those of CAFA2.
Conclusions
The top-performing methods in CAFA2 outperformed those from CAFA1. This increased accuracy can be attributed to a combination of the growing number of experimental annotations and improved methods for function prediction. The assessment also revealed that the definition of top-performing algorithms is ontology specific, that different performance metrics can be used to probe the nature of accurate predictions, and the relative diversity of predictions in the biological process and human phenotype ontologies. While there was methodological improvement between CAFA1 and CAFA2, the interpretation of results and usefulness of individual methods remain context-dependent.
The membrane protein EsaA is a conserved component of the type VIIb secretion system. Limited proteolysis of purified EsaA from Staphylococcus aureus USA300 identified a stable 48 kDa fragment, which was mapped by fingerprint mass spectrometry to an uncharacterized extracellular segment of EsaA. Analysis by circular dichroism spectroscopy showed that this fragment folds into a single stable domain made of mostly α‐helices with a melting point of 34.5°C. Size‐exclusion chromatography combined with multi‐angle light scattering indicated the formation of a dimer of the purified extracellular domain. Octahedral crystals were grown in 0.2 M ammonium citrate tribasic pH 7.0, 16% PEG 3350 using the hanging‐drop vapor‐diffusion method. Diffraction data were analyzed to 4.0 Å resolution, showing that the crystals belonged to the enantiomorphic tetragonal space groups P41212 or P43212, with unit‐cell parameters a = 197.5, b = 197.5, c = 368.3 Å, α = β = γ = 90°.
The heterotrimeric protein kinase SNF1 plays a key role in the metabolic adaptation of the pathogenic yeast Candida albicans. It consists of the essential catalytic α-subunit Snf1, the γ-subunit Snf4, and one of the two β-subunits Kis1 and Kis2. Snf4 is required to release the N-terminal catalytic domain of Snf1 from autoinhibition by the C-terminal regulatory domain, and snf4Δ mutants cannot grow on carbon sources other than glucose. In a screen for suppressor mutations that restore growth of a snf4Δ mutant on alternative carbon sources, we isolated a mutant in which six amino acids between the N-terminal kinase domain and the C-terminal regulatory domain of Snf1 were deleted. The deletion was caused by an intragenic recombination event between two 8-bp direct repeats flanking six intervening codons. In contrast to truncated forms of Snf1 that contain only the kinase domain, the Snf4-independent Snf1\(^{Δ311 − 316}\) was fully functional and could replace wild-type Snf1 for normal growth, because it retained the ability to interact with the Kis1 and Kis2 β-subunits via its C-terminal domain. Indeed, the Snf4-independent Snf1\(^{Δ311 − 316}\) still required the β-subunits of the SNF1 complex to perform its functions and did not rescue the growth defects of kis1Δ mutants. Our results demonstrate that a preprogrammed in-frame deletion event within the SNF1 coding region can generate a mutated form of this essential kinase which abolishes autoinhibition and thereby overcomes growth deficiencies caused by a defect in the γ-subunit Snf4.
Salmonella Typhimurium (S.Tm) is a common cause of self-limiting diarrhea. The mucosal inflammation is thought to arise from a standoff between the pathogen's virulence factors and the host's mucosal innate immune defenses, particularly the mucosal NAIP/NLRC4 inflammasome. However, it had remained unclear how this switches the gut from homeostasis to inflammation. This was studied using the streptomycin mouse model. S.Tm infections in knockout mice, cytokine inhibition and –injection experiments revealed that caspase-1 (not -11) dependent IL-18 is pivotal for inducing acute inflammation. IL-18 boosted NK cell chemoattractants and enhanced the NK cells' migratory capacity, thus promoting mucosal accumulation of mature, activated NK cells. NK cell depletion and Prf\(^{-/-}\) ablation (but not granulocyte-depletion or T-cell deficiency) delayed tissue inflammation. Our data suggest an NK cell perforin response as one limiting factor in mounting gut mucosal inflammation. Thus, IL-18-elicited NK cell perforin responses seem to be critical for coordinating mucosal inflammation during early infection, when S.Tm strongly relies on virulence factors detectable by the inflammasome. This may have broad relevance for mucosal defense against microbial pathogens.
Our body is colonized by a vast array of bacteria the sum of which forms our microbiota. The gut alone harbors >1,000 bacterial species. An understanding of their individual or synergistic contributions to human health and disease demands means to interfere with their functions on the species level. Most of the currently available antibiotics are broad‐spectrum, thus too unspecific for a selective depletion of a single species of interest from the microbiota. Programmable RNA antibiotics in the form of short antisense oligonucleotides (ASOs) promise to achieve precision manipulation of bacterial communities. These ASOs are coupled to small peptides that carry them inside the bacteria to silence mRNAs of essential genes, for example, to target antibiotic‐resistant pathogens as an alternative to standard antibiotics. There is already proof‐of‐principle with diverse bacteria, but many open questions remain with respect to true species specificity, potential off‐targeting, choice of peptides for delivery, bacterial resistance mechanisms and the host response. While there is unlikely a one‐fits‐all solution for all microbiome species, I will discuss how recent progress in bacterial RNA biology may help to accelerate the development of programmable RNA antibiotics for microbiome editing and other applications.
Analysis of a multi-component multi-stage malaria vaccine candidate—tackling the cocktail challenge
(2015)
Combining key antigens from the different stages of the P. falciparum life cycle in the context of a multi-stage-specific cocktail offers a promising approach towards the development of a malaria vaccine ideally capable of preventing initial infection, the clinical manifestation as well as the transmission of the disease. To investigate the potential of such an approach we combined proteins and domains (11 in total) from the pre-erythrocytic, blood and sexual stages of P. falciparum into a cocktail of four different components recombinantly produced in plants. After immunization of rabbits we determined the domain-specific antibody titers as well as component-specific antibody concentrations and correlated them with stage specific in vitro efficacy. Using purified rabbit immune IgG we observed strong inhibition in functional in vitro assays addressing the pre-erythrocytic (up to 80%), blood (up to 90%) and sexual parasite stages (100%). Based on the component-specific antibody concentrations we calculated the IC50 values for the pre-erythrocytic stage (17–25 μg/ml), the blood stage (40–60 μg/ml) and the sexual stage (1.75 μg/ml). While the results underline the feasibility of a multi-stage vaccine cocktail, the analysis of component-specific efficacy indicates significant differences in IC50 requirements for stage-specific antibody concentrations providing valuable insights into this complex scenario and will thereby improve future approaches towards malaria vaccine cocktail development regarding the selection of suitable antigens and the ratios of components, to fine tune overall and stage-specific efficacy.
The S flmbrial adhesln (Sfa) enables Esch richla colito attach to slalfc acld-containing receptor molecules of eukaryotJc cells. As prevlously reported, the genetlc determinant coding for the Sfa of an E. co/1 06 strain was cloned, the gene codlng for the major fimbrfal subunit was ldentlfled and sequenced and th.e S speclflc adhesin was detected. Here we present evidence that ln addltlon to the major subunit proteln SfaA three other minor subunit proteins, SfaG (17 kD), SfaS (14kD) and SfaH (31 kD) can be isolated from the S..speclfic flmbrial adhesln complex. The genes coding for these minor subunits were ldenblied, mutagenlzed separately and sequenced. Using haemagglutlnatton tests. electron-microscopy and quantitative ELISA assays with monoclonal anti-SfaA and anti-SfaS antlbodles the functlons of the minor subunlts were determined. lt was determlned that SfaS ls ldentlcal to the S-specific adhesln; whlch also plays a role ln deterrninatlon of the degree of fimbri· ation ofthe cell. The mlnor subunit SfaH also had some Jnfluence on the Ievei of fimbrlation of the cell. while StaG ls necessary for full expression of S·specific binding. lt was further shown that the amino-terminal proteln sequence of the isolated SfaS profein was identJcal to the proteln sequence calculated from the DNA sequence of the sfaS gene locus.
Analysis of host microRNA function uncovers a role for miR-29b-2-5p in Shigella capture by filopodia
(2017)
MicroRNAs play an important role in the interplay between bacterial pathogens and host cells, participating as host defense mechanisms, as well as exploited by bacteria to subvert host cellular functions. Here, we show that microRNAs modulate infection by Shigella flexneri, a major causative agent of bacillary dysentery in humans. Specifically, we characterize the dual regulatory role of miR-29b-2-5p during infection, showing that this microRNA strongly favors Shigella infection by promoting both bacterial binding to host cells and intracellular replication. Using a combination of transcriptome analysis and targeted high-content RNAi screening, we identify UNC5C as a direct target of miR-29b-2-5p and show its pivotal role in the modulation of Shigella binding to host cells. MiR-29b-2-5p, through repression of UNC5C, strongly enhances filopodia formation thus increasing Shigella capture and promoting bacterial invasion. The increase of filopodia formation mediated by miR-29b-2-5p is dependent on RhoF and Cdc42 Rho-GTPases. Interestingly, the levels of miR-29b-2-5p, but not of other mature microRNAs from the same precursor, are decreased upon Shigella replication at late times post-infection, through degradation of the mature microRNA by the exonuclease PNPT1. While the relatively high basal levels of miR-29b-2-5p at the start of infection ensure efficient Shigella capture by host cell filopodia, dampening of miR-29b-2-5p levels later during infection may constitute a bacterial strategy to favor a balanced intracellular replication to avoid premature cell death and favor dissemination to neighboring cells, or alternatively, part of the host response to counteract Shigella infection. Overall, these findings reveal a previously unappreciated role of microRNAs, and in particular miR-29b-2-5p, in the interaction of Shigella with host cells.
Over a period of 3 years, Legionella pneumophila serogroup 6 strains were isolated from warm water outlets and dental units in the Dental Faculty and from the Surgery and Internal Medicine Clinics at the University of Dresden, Dresden, Germany. In the bacteriological unit of the above-mentioned facility, L. pneumophila serogroups 3 and 12 were grown frl,)m warm water specimens. The medical facilities are located in separate buildings connected with a ring pipe warm water system. All L. pneumophila serogroup 6 strains isolated from the warm water supply reacted with a serogroup-specific monoclonal antibody, but not with two other monoclonal antibodies which are subgroup specific, reacting with other serogroup 6 strains. The NolI genomic profiles obtained by pulsed-field gel electrophoresis of 25 serogroup 6 strains isolated from the Dental Faculty over a 3-year period, 1 isolate from the Internal Medicine Clinic, and 4 strains from the Surgery Clinic were identical. Furthermore, all these strains hybridized with a 3OO-kb NolI fragment when a legiolysin (lIy)-specific DNA probe was used. The NolI pattern, however, differed from those of six serogroup 6 strains of other origins, one serogroup 12 strain from the bacteriological unit, and another six unrelated strains of serogroups other than serogroup 6. L. pneumophila serogroup 6 strains which can be divided into only two subgroups by the use of monoclonal antibodies are differentiated in at least six Noli cleavage types obtained by pulsed-field electrophoresis.
1. Summary Candida albicans is an opportunistic human fungal pathogen that causes a variety of infections, ranging from superficial mucosal to deep-seated systemic infections, especially in immunocompromised patients. Although the ability of C.albicans to cause disease largely depends on the immune status of the host, the fungus also exhibits specific characteristics that facilitate colonization, dissemination, and adaptation to different host niches and thereby turn C.albicans from a harmless commensal to an aggressive pathogen. In response to various environmental stimuli C.albicans switches from growth as a budding yeast to invasive filamentous growth, and this morphogenetic switch plays an important role in C.albicans pathogenesis. Nitrogen limitation is one of the signals that induce filamentous growth in C.albicans, and the control of the morphogenetic transition by nitrogen availability was studied in detail in the present work. Ammonium is a preferred nitrogen source for yeasts that is taken up into the cells by specific transporters. It was found in this study that C.albicans possesses two major ammonium transporters, encoded by the CaMEP1 and CaMEP2 genes, expression of which is induced by nitrogen starvation. Whereas mep1 or mep2 single mutants grew as well as the wild-type strain on limiting concentrations of ammonium, deletion of both transporters rendered C.albicans unable to grow at ammonium concentrations below 5 mM. In contrast to mep1 mutants, mep2 mutants failed to filament and grew only in the yeast form under nitrogen starvation conditions, indicating that in addition to its role as an ammonium transporter CaMep2p also has a signaling function in the induction of filamentous growth. CaMep2p was found to be a less efficient ammonium transporter than CaMep1p and to be expressed at much higher levels, a distinguishing feature important for its signaling function. By the construction and analysis of serially truncated versions of CaMep2p, the C-terminal cytoplasmic tail of the protein was shown to be essential for signaling but dispensable for ammonium transport, demonstrating that these two functions of CaMep2p are separable. In C.albicans at least two signal transduction pathways, a MAP kinase cascade and a cAMP-dependent pathway ending in the transcriptional regulators Cph1p and Efg1p, respectively, control filamentous growth, and mutants defective in either one of these pathways are defective for filamentation under nitrogen starvation conditions. A hyperactive CaMEP2 allele rescued the filamentation defect of a cph1 or a efg1 mutant, but not of a cph1 efg1 double mutant or a mutant deleted for RAS1, which acts upstream of and activates both signaling pathways. Conversely, a dominant active RAS1 allele or addition of exogenous cAMP rescued the filamentation defect of mep2 mutants. These results suggest that CaMep2p activates both the MAP kinase and the cAMP pathway in a Ras1p dependent manner to promote filamentous growth under nitrogen starvation conditions. At sufficiently high concentrations, ammonium repressed filamentous growth even when the signaling pathways were artificially activated. Therefore, C.albicans has established a regulatory circuit in which a preferred nitrogen source, ammonium, serves as an inhibitor of morphogenesis that is taken up into the cell by the same transporter that induces filamentous growth in response to nitrogen starvation. Although a detailed understanding of virulence mechanisms of C.albicans may ultimately lead to novel approaches to combat infections caused by this pathogen, the identification and characterization of essential genes as potential targets for the development of antifungal drugs is a strategy favoured by most pharmaceutical companies. Therefore, C.albicans homologs of three genes that are essential in other fungi were selected in collaboration with an industrial partner and functionally characterized in this work. RAP1 encodes the repressor/activator protein 1, a transcription factor and telomere binding protein that is essential for viability in the budding yeast Saccharomyces cerevisiae. However, deletion of the C.albicans RAP1 homolog did not affect viability or growth of the mutants, suggesting that it is not a promising target. CBF1 (centromere binding factor 1) is necessary for proper chromosome segregation and transcriptional activation of methionine biosynthesis genes in S.cerevisiae and is essential for viability in the related yeasts Kluyveromyces lactis and Candida glabrata. Deletion of CBF1 in C.albicans did not result in an increased frequency of chromosome loss, indicating that it has no role in chromosome segregation in this organism. However, the C.albicans cbf1 mutants exhibited severe growth impairment, temperature sensitivity at 42°C, and auxotrophy for sulphur amino acids, suggesting that Cbf1p is a transcription factor that is important for normal growth of C.albicans. YIL19 is an essential gene in S.cerevisiae that is involved in 18S rRNA maturation. YIL19 was found to be an essential gene also in C.albicans. Conditional mutants in which the YIL19 gene could be excised from the genome by inducible, FLP-mediated recombination were non-viable and accumulated rRNA precursors, demonstrating that YIL19 is essential for this important cellular process and for viability of C.albicans and could serve as a target for the development of antifungal drugs.
Freshly isolated human T lymphocytes were tested for their response to mycobacteria, mycobacteriallysates, 2 dimensional (2D) PAGE separated mycobacteriallysates, leishmania and defined leishmanial antigen preparations. While,o T cells proliferated vigourously in the presence of mycobacteria and mycobacteria derived lysates, a significant stimulation from 2 D gel separated lysates was not detected. In addition '10 T cells failed to respond towards leishmania or leishmanial components. In the ab T cell compartment some donors, presumably according to their state of immunity against mycobacteria, responded to mycobacteria, mycobacterial lysates and 2 D gel separated mycobacterial lysates. Neither freshly isolated '10 T cells nor ab T cells from naive donors did mount a significant immune response against leishmania.
The obligate intracellular gram-negative bacterium, Chlamydophila pneumoniae (Cpn), has a significant impact as an acute and chronic disease-causing pathogen. Its potential to undergo persistent infections has been linked to chronic diseases. Several in vitro cell culture models are used to study persistent conditions, mainly IFN_ stimulation, treatment with antibiotics and iron depletion. Little is known about changes in the Cpn transcriptome during the acute and persistent infection. Therefore, the Cpn transcriptome during its acute developmental cycle and iron depletion-mediated persistence was examined in this study. Based on expression profiles, genes with similar expression changes formed 12 clusters using the self-organizing map algorithm. While other studies define genes based on their onset of transcription, here the important feature for clustering was the expression profile. This turned out to be more appropriate for comparing the time specific relevance of a certain cluster of genes to their proposed functions in the cycle. The Cpn clusters were grouped into the 'Early', 'Mid' and 'Late' classes as described for Ctr. Additionally, a new gene expression class containing genes with steadily increasing expression at the end of the developmental cycle was defined and termed 'Tardy' class. Comparison of the Cpn clusters to published proteomics data showed that genes encoding elementary body (EB) proteins peaked in the 'Late' gene cluster. This indicated that genes of the ‘Late’ and ‘Tardy’ class have different roles in RB to EB re-differentiation. Moreover, using lexical comparison the EB mRNA profile was significantly linked to the ‘Tardy’ cluster class. This provided evidence that initial translation in the cycle might be directed from stable transcripts present in the infectious EB form. Based on these criteria the novel ‘Tardy’ class was separated from the ‘Late’ class. The gene ontologies were used to identify specific pathways and physiological functions active during the different phases of development. Additionally, the transcriptome of Cpn in the persistent stage was compared to that of the acute developmental cycle. The Cpn transcriptome was altered in the iron-depletion mediated persistence. Genes upregulated were linked to clusters at the beginning of the developmental cycle, and genes down-regulated were linked to clusters at the end of the developmental cycle. These data provided strong evidence that the Cpn transcriptome during persistence is a gene expression arrest in mid-development. In early acute infection convergently or divergently oriented gene pairs preferentially had an antagonistic expression profile, whereas tandemly oriented gene pairs showed a correlated expression profile. This suggests that the Cpn genome is organized mainly in tandemly arranged operons and in convergently or divergently oriented genes with favored antagonistic profiles. The microarray studies done with the Cpn strain CWL029 also showed expression signals for several genes annotated only for the Cpn strains AR39 and J138. BLAST comparison verified that these genes are also coded in the CWL029 genome. Several of these genes were convergently arranged with their neighboring gene and shared overlapping genome information. Among these were parB, involved in DNA segregation and rpsD, an alternative sigma factor responsible for the transcription at late stages of the developmental cycle. Both genes have been described to have major roles in the chlamydial cycle. These genes had an antagonistic expression profile at the beginning of the acute developmental cycle and in persistence, as described before to be predominant for convergently oriented genes. Real time RT-PCR analysis showed that full-length rpsD mRNA transcripts were down-regulated, whereas short-length rpsD mRNA transcripts were up-regulated during the persistent infection. This demonstrated that the rpsD promoter is activated during the persistent infection and that because of the collision of the RNA polymerases full length transcripts were down-regulated. This sigma factor-independent mechanism is known as ‘Transcriptional Interference’. This is the first description on how the alternative sigma factor rpsD might be down-regulated during persistent infections. Finally, the host cell transcriptome was analyzed in the acute and persistent infection mediated by the depletion of iron. Cpn infection triggered the upregulation of relB, involved in an alternative NF-KB signaling pathway. Several genes coding for cell cycle proteins were triggered, including cyclin G2 and cyclin D1 and inhibitors of CDK4. Taken together, this work provides insights into the modulation of the pathogen and the host transcriptome during the acute infection and the iron mediated persistent infection.
The haemolysin (hly) determinant of the plasmid pHly152 contains an IS2 element at 469 bp upstream of the hlyC gene. The sequence at the other (right-hand) end (RS) also shows multiple hybridization with the plasmid pHly152 and the chromosome of some Escherichia coli strains but the nucleotide sequence of this region does not reveal the typical properties of an IS element. Similar arrangements in the regions flanking the hly determinant are also found on various Hly plasmids from uropathogenic E. coli strains. Chromosomal hly determinants Iack both flanking sequences (IS2 and RS) in the immediate vicinity of the hly genes. The sequences immediately upstream of the hlyC gene have been determined from several chromosomal hly determinants and compared with the corresponding sequence of the hly determinant of the plasmid pHly152. We show that these sequences, which contain one promoter (left promoter, phlyL) in all hly determinants tested, vary considerably although common sequence elements can still be identified. In contrast, only relatively few nucleotide exchanges have been detected in the adjacent structural hlyC genes. The A + T content of the 200 bp sequence upstream of hlyC is very high (72 mol% A + T) but even the structural hly genes show a considerably higher A + T content (about 60 mol%) than the E. coli chromosome on average (50 mol% A+T) suggesting that the hly determinant may not have originated in E. coli.
Recently we have described the molecular cloning of the genetic determinant coding for the S-fimbrial adhesin (Sfa), a sialic acid-recognizing pilus frequently found among extraintestinal Eschenchili coli isolates. Fimbriae from the resulting Sfa + E. coli K-12 clone were isolated, and an Sfa-specific antiserum was prepared. Western blots indicate that S fimbriae isolated from different uropathogenic and meningitis-associated E. coli strains, including 083:Kl isolates, were serologically related. The Sfa-specific antibodies did not cross-react with P fimbriae, but did cross-react with FlC fimbriae. Furthermore the sja+ recombinant DNAs and some cloned s/a-flanking regions were used as probes in Southem experiments. Chromosomal DNAs isolated from 018:Kl and 083:Kl meningitis strains with and without S fimbriae and from uropathogenic 06:K + strains were hybridized against these sfa-specific probes. Only one copy of the sfa determinant was identified on the chromosome of these strains. No sfa-specific sequences were observed on the chromosome of E. coli K-12 strains and an 07:Kl isolate. With the exception of small alterations in the sfa-coding region the genetic determinants for S fimbriae were identical in uropathogenic 06:K + and meningitis 018:Kl and 083:Kl strains. The sfa determinant was also detected on the chromosome of Kl isolates with an Sfa-negative phenotype, and specific cross-hybridization signals were visible after blotting against FlC-specific DNA. In addition homology among the different strains was observed in the sfa-flanking regions.
In the last years more than one hundred microbial genomes have been sequenced, many of them from pathogenic bacteria. The availability of this huge amount of sequence data enormously increases our knowledge on the genome structure and plasticity, as well as on the microbial diversity and evolution. In parallel, these data are the basis for the scientific “revolution” in the field of industrial and environmental biotechnology and medical microbiology – diagnostics and therapy, development of new drugs and vaccines against infectious agents. Together with the genomic approach, other molecular biological methods such as PCR, DNA-chip technology, subtractive hybridization, transcriptomics and proteomics are of increasing importance for research on infectious diseases and public health. The aim of this work was to characterize the genome structure and -content of the probiotic Escherichia coli strain Nissle 1917 (O6:K5:H31) and to compare these data with publicly available data on the genomes of different pathogenic and non-pathogenic E. coli strains and other closely related species. A cosmid genomic library of strain Nissle 1917 was screened for clones containing the genetic determinants contributing to the successful survival in and colonization of the human body, as well as to mediate this strain’s probiotic effect as part of the intestinal microflora. Four genomic islands (GEI I-IVNissle 1917) were identifed and characterized. They contain many known fitness determinants (mch/mcm, foc, iuc, kps, ybt), as well as novel genes of unknown function, mobile genetic elements or newly identified putative fitness-contributing factors (Sat, Iha, ShiA-homologue, Ag43-homologues). All islands were found to be integrated next to tRNA genes (serX, pheV, argW and asnT, respectively). Their structure and chromosomal localization closely resembles those of analogous islands in the genome of uropathogenic E. coli strain CFT073 (O6:K2(?):H1), but they lack important virulence genes of uropathogenic E. coli (hly, cnf, prf/pap). Evidence for instability of GEI IINissle 1917 was given, since a deletion event in which IS2 elements play a role was detected. This event results in loss of a 30 kb DNA region, containing important fitness determinants (iuc, sat, iha), and therefore probably might influence the colonization capacity of Nissle 1917 strain. In addition, a screening of the sequence context of tRNA-encoding genes in the genome of Nissle 1917 was performed to identify genome wide potential integration sites of “foreign” DNA. As a result, similar “tRNA screening patterns” have been observed for strain Nissle 1917 and for the uropathogenic E. coli O6 strains (UPEC) 536 and CFT073. I. Summary 4 The molecular reason for the semi-rough phenotype and serum sensitivity of strain Nissle 1917 was analyzed. The O6-antigen polymerase-encoding gene wzy was identified, and it was shown that the reason for the semi-rough phenotype is a frame shift mutation in wzy, due to the presence of a premature stop codon. It was shown that the restoration of the O side-chain LPS polymerization by complementation with a functional wzy gene increased serumresistance of strain Nissle 1917. The results of this study show that despite the genome similarity of the E. coli strain Nissle 1917 with the UPEC strain CFT073, the strain Nissle 1917 exhibits a specific set of geno- and phenotypic features which contribute to its probiotic action. By comparison with the available data on the genomics of different species of Enterobacteriaceae, this study contributes to our understanding of the important processes such as horizontal gene transfer, deletions and rearrangements which contribute to genome diversity and -plasticity, and which are driving forces for the evolution of bacterial variants. At last, the fim, bcs and rfaH determinats whose expression contributes to the mutlicellular behaviour and biofilm formation of E. coli strain Nissle 1917 have been characterized.
Analysis of the mechanism and the regulation of histatin 5 resistance in \(Candida\) \(albicans\)
(2018)
Antimycotics such as fluconazole are frequently used to treat C. albicans infections of the oral mucosa. Prolonged treatment of the fungal infection with fluconazole pose a risk to resistance development. C. albicans can adapt to these stressful environmental changes by regulation of gene expression or by producing genetically altered variants that arise in the population. Adapted variants frequently carry activating mutations in zinc cluster transcription factors, which cause the upregulation of their target genes, including genes encoding efflux pumps that confer drug resistance. MDR1, regulated by the zinc cluster transcription factor Mrr1, as well as CDR1 and CDR2, regulated by the zinc cluster transcription factor Tac1, are well-known examples of genes encoding efflux pumps that extrude the antimycotic fluconazole from the fungal cell and thus contribute to the survival of the fungus.
In this study, it was investigated if C. albicans can develop resistance to the antimicrobial peptide histatin 5, which serves as the first line of defence in the oral cavity of the human host. Recently, it was shown that C. albicans transports histatin 5 outside of the Candia cell via the efflux pump Flu1. As efflux pumps are often regulated by zinc cluster transcription factors, the Flu1 efflux pump could also be regulated by a zinc cluster transcription factor which could in a hyperactive form upregulate the expression of the efflux pump, resulting in increased export of histatin 5 and consequently in histatin 5 resistance.
In order to find a zinc cluster transcription factor that upregulates FLU1 expression, a comprehensive library of C. albicans strains containing artificially activated forms of zinc cluster transcription factors was screened for suitable candidates. The screening was conducted on medium containing mycophenolic acid because mycophenolic acid is also a substrate of Flu1 and a strain expressing a hyperactive zinc cluster transcription factor that upregulates FLU1 expression should exhibit an easily recognisable mycophenolic acid-resistant phenotype. Further, FACS analysis, quantitative real-time RT-PCR analysis, broth microdilution assays as well as histatin 5 assays were conducted to analyse the mechanism and the regulation of histatin 5 resistance.
Several zinc cluster transcription factors caused mycophenolic acid resistance and upregulated FLU1 expression. Of those, only hyperactive Mrr1 was able to confer increased histatin 5 resistance. Finding Mrr1 to confer histatin 5 resistance was highly interesting as fluconazole-resistant strains with naturally occurring Mrr1 gain of function mutations exist, which were isolated from HIV-infected patients with oral candidiasis. These Mrr1 gain of function mutations as well as artificially activated Mrr1 cause fluconazole resistance by upregulation of the efflux pump MDR1 and other target genes. In the course of the study, it was found that expression of different naturally occurring MRR1 gain-of-function mutations in the SC5314 wild type background caused increased FLU1 expression and increased histatin 5 resistance. The same was true for fluconazole-resistant clinical isolates with Mrr1 gain of function mutations, which also caused the overexpression of FLU1. Those cells were less efficiently killed by histatin 5 dependent on Mrr1. Surprisingly, FLU1 contributed only little to histatin 5 resistance, rather, overexpression of MDR1 mainly contributed to the Mrr1-mediated histatin 5 resistance, but also additional Mrr1-target genes were involved. These target genes are yet to be uncovered. Moreover, if a link between the yet unknown Mrr1-target genes contributing to fluconazole resistance and increased histatin 5 resistance can be drawn remains to be discovered upon finding of the responsible target genes.
Collectively, this study contributes to the understanding of the impact of prolonged antifungal exposure on the interaction between host and fungus. Drug therapy can give rise to resistance evolution resulting in strains that have not only developed resistance to fluconazole but also to an innate host mechanism, which allows adaption to the host niche even in the absence of the drug.
The uropathogenic Escherichia coli wiJd..:type strain 536 produces S-fimbriae, P-related fimbriae and type I fimbriae. Using immuno-colony dot and ELISA techniques, variants were detected showing an increased degree of S-fimbrial production. It was demonstrated by itrtmunofluorescence microscopy that in noimal (wild-type) and hyperS- fimbriated E. coli populaiions non-fimbriated cells also · exist, and that the percentage of Sfinibrlated and non-fimbriated bacteria was roughly identica1 in either population. Hyper-Sfimbriated variants could be stably maintained. The transition from wild-type to hyper-S-fimbriation, which occurs spontaneously, is markedly higher than vice versa. Southern blot analysis of the S fimbrial adhesin (sfa) determinants of normal and hyper-fimbriated strains revealed no marked difference in the gene structure.
Legionella pneumophila, the causative agent of Legionnaires' disease is a facultative intracellular bacterium, which in the course of human infection multiplies in lung macrophages predominantly manifesting as pneumonia. The natural habitat of Legionella is found in sweet water reservoirs and man-made water systems. Virulent L. pneumophila spontaneously convert to an avirulent status at a high frequency. Genetic approaches have led to the identification of various L. pneumophila genes. The mip (macrophage infectivity potentiator) determinant remains at present the sole established virulence factor. The Mip protein exhibits activity of a peptidyl prolyl cis trans isomerase (PPiase), an enzyme which is able to bind the immunosuppressant FK506 and is involved in protein folding. The recently cloned major outer membrane protein (MOMP) could play a role in the uptake of legionellae by macrophages. Cellular models are useful in studying the intracellular replication of legionellae in eukaryotic cells. Human celllines and protozoan models are appropriate for this purpose. By using U 937 macrophage-like cells and Acanthamoeba castellanii as hosts, we could discriminate virulent and avirulent L. pneumophila variants since only the virulent strain was capable of intracellular growth at 37 oc. By using these systems we further demonstrated that a hemolytic factor cloned and characterized in our laboratory, legiolysin (lly), had no influence on the intracellular growth of L. pneumophila.
To understand the gene regulation of an organism of interest, a comprehensive genome annotation is essential. While some features, such as coding sequences, can be computationally predicted with high accuracy based purely on the genomic sequence, others, such as promoter elements or noncoding RNAs, are harder to detect. RNA sequencing (RNA-seq) has proven to be an efficient method to identify these genomic features and to improve genome annotations. However, processing and integrating RNA-seq data in order to generate high-resolution annotations is challenging, time consuming, and requires numerous steps. We have constructed a powerful and modular tool called ANNOgesic that provides the required analyses and simplifies RNA-seq-based bacterial and archaeal genome annotation. It can integrate data from conventional RNA-seq and differential RNA-seq and predicts and annotates numerous features, including small noncoding RNAs, with high precision. The software is available under an open source license (ISCL) at https://pypi.org/project/ANNOgesic/.